Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
AbstractNon-transplanted and transplanted patients with chronic kidney disease (CKD) differ in terms of mortality and the risk of clinical events. This difference is probably due to the difference of both traditional and non-traditional risk factors. Uremic retention solutes may constitute important non-traditional risk factors in this population. In the present review, we selected a set of uremic toxins that have been associated with harmful effects, and are an appealing target for adjuvant therapy in CKD. For each toxin reviewed here, relevant studies were selected and the relationship with hard clinical outcomes of uremic toxins were compared between non-transplanted CKD patients and transplanted patients taking into account the level of glomerular filtration rate in these two situations. View Full-Text
Share & Cite This Article
Liabeuf, S.; Cheddani, L.; Massy, Z.A. Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation. Toxins 2018, 10, 229.
Liabeuf S, Cheddani L, Massy ZA. Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation. Toxins. 2018; 10(6):229.Chicago/Turabian Style
Liabeuf, Sophie; Cheddani, Lynda; Massy, Ziad A. 2018. "Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation." Toxins 10, no. 6: 229.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.